Skip to content
Search

Latest Stories

NHS Pharmacists to receive 5.5% pay increase; PDA welcomes the decision

NHS Pharmacists to receive 5.5% pay increase; PDA welcomes the decision
Chancellor Rachel Reeves announces pay increase for NHS pharmacists alongside other NHS staff, fully accepting the Pay Review Bodies' recommendations

The Pharmacists' Defence Association (PDA) has welcomed the Chancellor’s announcement of a 5.5 percent pay increase for NHS pharmacists.

Following the acceptance of the NHS Pay Review Body's (PRB) recommendations, Chancellor Rachel Reeves shared the announcement in a speech to Parliament on 29 July.


She confirmed that the pay review bodies' recommendations for health and education for 2024-25 would be fully implemented.

Reeves' speech came alongside the release of her audit into public finances, a commitment she made shortly after the recent election.

The audit confirms that the recommendations from various PRBs, including those for NHS staff, doctors, dentists, teachers, and other public servants, have been approved and will be acted upon.

"That is the right decision for the people who work in and most importantly the people who use our public services...giving hardworking staff the pay rise they deserve while ensuring we can recruit and retain the people we need," Reeves announced.

"It should not have taken this long to come to these decisions."

In February, the PDA submitted detailed evidence to the PRB, calling for targeted pay increases for NHS pharmacists, especially those at the top of the Agenda for Change (AfC) pay bands.

The PDA's submission highlighted the significant erosion of purchasing power for these pharmacists and stressed the need for specific attention to the top AfC bands.

Some of the key points that PDA had submitted as written evidence included  the PRB to prioritise pay rates at the top of AfC bands 5-8, where purchasing power has significantly diminished.

  • Uniform Pay Increase: While the PDA supports a general pay increase for all NHS workers, it emphasizes the need for specific focus on the top AfC bands.
  • Avoiding Lower Pay Points: This year’s recommendations should not focus on lower pay points, which have already been addressed in previous awards and restructuring.
  • Above-Inflation Pay Rise: The PDA believes that an above-inflation increase is fair and necessary for pharmacists.

Commenting on the new development, Paul Day, PDA Union Director, said: "The increase announced by the Chancellor meets the PDA’s call and is significantly above inflation.

"This increase is for all NHS workers and is therefore a real terms increase for all pharmacists employed on AfC terms and conditions.

"It is an encouraging sign in the first few months of the new administration that, considering the economic circumstances they have inherited, this announcement suggests that they have listened to the evidence presented by the PDA and others and value public sector workers.

"Nevertheless, the PDA recognises this is only a small step towards redressing previous years of low increases, particularly for experienced and long serving pharmacists."

More For You

Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less